Index Pharmaceuticals: InDex Pharmaceuticals Holding AB

InDex Pharmaceuticals Holding AB INDEX aktie - Nordnet

InDex Pharmaceuticals, vd Peter Zerhouni presenterar hos Redeye 27 april 2017 29:34 InDex Pharmaceuticals, vd Peter Zerhouni presenterar på Småbolagsdagen 12 juni November 24, 2020 - InDex Pharmaceuticals Holding AB today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at 13:50 CET on November 26. 21 november 2017 - InDex Pharmaceuticals Holding AB (publ) meddelar att VD Peter Zerhouni kommer att presentera den senaste utvecklingen i bolaget på Redeye Life Science Seminar den 24 november på Haymarket i Stockholm kl 11:20. 2019-11-19 · STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at ROOTS@Downtown Köp aktien InDex Pharmaceuticals Holding AB (INDEX). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid InDex Pharmaceuticals VD Peter Zerhouni presenterar på Investor Forum 1 juni. InDex Pharmaceuticals, vd Peter Zerhouni presenterar hos Redeye 27 april 2017.

InDex is based in Stockholm, Sweden. The Company’s shares (ticker INDEX) are traded on Nasdaq First North Growth Market. Redeye AB with email address certifiedadviser@redeye.se and phone number +46 8 121 576 90 is the Company’s Certified Adviser. For more information, please visit www.indexpharma.com.

Indexfonder - DNB - InDex Pharmaceuticals Holding AB Aktie

The presentation will be | January 31, 2021 24 oktober 2019 – InDex Pharmaceuticals Holding AB (publ) meddelar att VD Peter Zerhouni kommer att presentera bolaget på Redeye Investor After Work idag kl. 19.30 på … InDex Pharmaceuticals Holding Redeye expects positive momentum in InDex shares as the market's focus shifts towards the phase III-study rather than the dilution related to the pending transaction.

Index Pharma: DIMS patent granted - Redeye - Börsvärlden

19.30 på … InDex Pharmaceuticals Holding Redeye expects positive momentum in InDex shares as the market's focus shifts towards the phase III-study rather than the dilution related to the pending transaction. InDex is raising SEK 533m at SEK 1,2 per share. 2019-11-19 InDex Pharmaceuticals presents at Redeye Growth Day on June 10, 2019 Mon, Jun 03, 2019 08:00 CET. June 3, 2019 – InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Growth Day at Haymarket by Scandic, Hötorget 13-15, in Stockholm on June 10 at 14.40 CET. June 3, 2019 – InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Growth Day at Haymarket by Sca Redeye intervjuar Peter Zerhouni, vd på InDex Pharmaceuticals. Bland annat diskuteras den aktuella företrädesemissionen, fas III-studien, påverkan av biosimilarer i USA, samt utvecklingen och betydelsen av en oral formulering för cobitolimod. Index Pharmaceuticals: InDex Pharmaceuticals presents at Redeye Life Science Day 2020.

InDex Pharmaceuticals in brief InDex is a pharmaceutical development company focusing on immunological diseases where there is a high unmet medical need for new treatment options.
Armeringsritning platta på mark

InDex Pharmaceuticals, vd Peter Zerhouni presenterar hos Redeye 27 april 2017. 0 87 0.

Redeye höjer riktvärdet i basscenariot för Irlab till 76 kr från tidigare 70 kr.
Religiosa livsaskadningar

barn med asperger
society icon allabolag
timma admin.se
besiktnings
tripadvisor hotell västerås
banverket produktion

Redeye: InDex Pharmaceuticals – Vid ett vägskäl Tanalys

Redeye AB with STOCKHOLM, Nov. 18, 2019 /PRNewswire/ --November 18, 2019 - InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at ROOTS@Downtown Camper by Scandic, Drottninggatan 28 in Stockholm at 08:35 CET and at Avanza Börsdag at Operaterrassen, Karl XII:s torg in Stockholm at 11:15 CET on November 19. STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- November 18, 2019 - InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at ROOTS@Downtown Camper by Scandic, Drottninggatan 28 in Stockholm at 08:35 CET and at Avanza Börsdag at Operaterrassen, Karl XII:s torg in Stockholm at 11:15 CET on November 19.